PirtobrUtinib as Frontline Therapy for Elderly Unfit/Frail Patient With MAntle Cell Lymphoma
Clinical trial NCT07207785 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07207785
- Sponsor
- Fondazione Italiana Linfomi - ETS
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-01
- Primary completion
- 2028-02-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.